Erasca, Inc. (ERAS)
NASDAQ·Healthcare·Biotechnology
$9.75
-49.09%
Mkt Cap $6.73B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | — | — | — | -$0.11 | -$0.10 | +9.09% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$0.11 | -$0.11 | +0.00% | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | -$0.12 | -$0.12 | +0.00% | — | — |
| Q2 2025 May 13, 2025 | — | — | — | -$0.12 | -$0.11 | +8.33% | — | — |
| Q1 2025 Mar 20, 2025 | — | — | — | -$0.12 | -$0.11 | +8.33% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.17 | -$0.11 | +35.29% | — | — |
| Q3 2024 Aug 12, 2024 | — | — | — | -$0.17 | -$0.29 | -70.59% | — | — |
| Q2 2024 May 8, 2024 | — | — | — | -$0.21 | -$0.23 | -9.52% | — | — |
| Q1 2024 Mar 27, 2024 | — | $5.58M | — | -$0.24 | -$0.20 | +16.67% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.21 | -$0.20 | +4.76% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.27 | -$0.21 | +22.22% | — | — |
| Q2 2023 May 15, 2023 | — | — | — | -$0.30 | -$0.22 | +26.67% | — | — |
| Q1 2023 Mar 23, 2023 | — | — | — | -$0.30 | -$0.28 | +6.67% | — | — |
| Q4 2022 Nov 9, 2022 | — | — | — | -$0.31 | -$0.29 | +6.45% | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | -$0.34 | -$0.30 | +11.76% | — | — |
| Q2 2022 May 12, 2022 | — | — | — | -$0.30 | -$0.31 | -3.33% | — | — |
| Q1 2022 Mar 24, 2022 | — | — | — | -$0.31 | -$0.26 | +16.13% | — | — |
| Q4 2021 Nov 10, 2021 | — | — | — | -$0.32 | -$0.27 | +15.62% | — | — |
| Q3 2021 Aug 26, 2021 | — | — | — | -$0.65 | -$1.20 | -84.62% | — | — |
| Q3 2021 Jul 16, 2021 | — | — | — | — | -$0.10 | — | — | — |